Form 13-F position report

KINDRED BIOSCIENCES, INC COM S

Reported by BLACKROCK ADVISORS LLC

KIN CUSIP 494577109 Manager CIK 0001086364

Reported 23,195 shares, down 1,201 (4.9%) from the prior quarter.

Reported value -18.9%; share count -4.9% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q4 2016
Shares 23,195 Quarter-end amount reported
Reported value $99,000 Fair value at quarter end
Consecutive quarters held 12 Through Q4 2016

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2014-03-31 96000
2014-06-30 83000
2014-09-30 651000
2014-12-31 633000
2015-03-31 612000
2015-06-30 539000
2015-09-30 97000
2015-12-31 67000
2016-03-31 85000
2016-06-30 93000
2016-09-30 122000
2016-12-31 99000

Quarterly position history

How this manager's reported quarter-end position changed over time.

12 quarters
Quarterly reported position history for KINDRED BIOSCIENCES, INC COM S held by BLACKROCK ADVISORS LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2016 Reduced 23,195 -1,201 (-4.9%) < 0.01% $99,000 2017-02-10
Q3 2016 Reduced 24,396 -1,775 (-6.8%) < 0.01% $122,000 2016-11-08
Q2 2016 Added 26,171 +1,453 (5.9%) < 0.01% $93,000 2016-08-10
Q1 2016 Added 24,718 +4,986 (25.3%) < 0.01% $85,000 2016-05-10
Q4 2015 Added 19,732 +1,043 (5.6%) < 0.01% $67,000 2016-02-11
Q3 2015 Reduced 18,689 -60,407 (-76.4%) < 0.01% $97,000 2015-11-13
Q2 2015 Reduced 79,096 -6,555 (-7.7%) < 0.01% $539,000 2015-08-07
Q1 2015 Added 85,651 +693 (0.8%) < 0.01% $612,000 2015-05-13
Q4 2014 Added 84,958 +14,567 (20.7%) < 0.01% $633,000 2015-02-09
Q3 2014 Added 70,391 +65,923 (1475.4%) < 0.01% $651,000 2014-10-29
Q2 2014 Reduced 4,468 -699 (-13.5%) < 0.01% $83,000 2014-08-06
Q1 2014 New 5,167 +5,167 (0.0%) < 0.01% $96,000 2014-05-02

Who else reported the position

44 managers reported KINDRED BIOSCIENCES, INC COM S for Q4 2016.

Managers reporting KINDRED BIOSCIENCES, INC COM S in Q4 2016.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ARIEL INVESTMENTS LLC Added 3,940,859 +105,696 0.2% $16,749,000 9 qtrs
Park West Asset Management LLC Added 1,989,084 +38,295 0.65% $8,454,000 6 qtrs
MORGAN STANLEY Added 1,800,738 +1,776,239 < 0.01% $7,653,000 13 qtrs
DIMENSIONAL FUND ADVISORS LP Added 1,334,953 +1,310,155 < 0.01% $5,674,000 6 qtrs
EcoR1 Capital LLC Reduced 571,126 -861,639 0.77% $2,427,000 9 qtrs
VANGUARD GROUP INC Reduced 428,648 -5,689 < 0.01% $1,822,000 12 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 351,600 +20,000 < 0.01% $1,494,000 9 qtrs
NEW YORK STATE COMMON RETIREMENT FUND Added 327,043 +6,842 < 0.01% $1,390,000 7 qtrs
WELLS FARGO & COMPANY MN Added 326,352 +116,725 < 0.01% $1,387,000 11 qtrs
Granite Investment Partners LLC New 152,959 +152,959 0.05% $650,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2016
Filed
February 10, 2017
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
23,195
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.